CytoMed Therapeutics Stock Quote GDTC - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.98

Bid

1.96

Ask

2.14

Volume

2,502

1.97 Day's Range 1.98

1.89 52 Week Range 9.25

Market Cap

22.849M

Previous Close

1.92

Open

1.97

Last Trade

1.96

Last Trade Time

Financial Volume

$ 4,942

VWAP

1.9753

Average Volume (3m)

4,669

Shares Outstanding

11,540,000

Dividend Yield

PE Ratio

-5.53

Earnings Per Share (EPS)

-0.36

Revenue

518k

Net Profit

-4.13M

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cytomed.sg.

Headquarters

Singapore, Sgp

Founded

1970

CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was $1.92. Over the last year, CytoMed Therapeutics shares have traded in a share price range of $ 1.89 to $ 9.25.

CytoMed Therapeutics currently has 11,540,000 shares outstanding. The market capitalization of CytoMed Therapeutics is $22.85 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -5.53.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.09	-4.34782608696	2.07	2.08	1.89	2974	1.93984478	CS
4	-0.11	-5.26315789474	2.09	2.169	1.89	2962	2.02558199	CS
12	-0.2	-9.17431192661	2.18	2.48	1.89	4669	2.08981756	CS
26	-2.34	-54.1666666667	4.32	5.5	1.89	30154	3.7465534	CS
52	-0.89	-31.0104529617	2.87	9.25	1.89	125839	5.06030267	CS
156	-2.02	-50.5	4	9.25	1.89	130659	4.78556432	CS
260	-2.02	-50.5	4	9.25	1.89	130659	4.78556432	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AREBAmerican Rebel Holdings Inc	$ 0.76 (152.49%)	371.46M
SHCRSharecare Inc	$ 1.365 (76.27%)	56.33M
NXLNexalin Technologies Inc	$ 1.7499 (59.08%)	57.58M
FUFUBitFuFu Inc	$ 6.1209 (56.95%)	2.5M
SPECSpectaire Holdings Inc	$ 0.50 (47.06%)	65.27M
FLFVFeutune Light Acquisition Corporation	$ 2.5502 (-69.75%)	862.38k
FLFVUFeutune Light Acquisition Corporation	$ 2.75 (-66.83%)	16.5k
RWODRedwoods Acquisition Corporation	$ 2.34 (-60.34%)	155.96k
KAVLKaival Brands Innovations Group Inc	$ 1.23 (-57.14%)	4.92M
RWODURedwoods Acquisition Corporation	$ 3.24 (-56.28%)	1.47k
NVDANVIDIA Corporation	$ 126.57 (-3.22%)	658.13M
AREBAmerican Rebel Holdings Inc	$ 0.76 (152.49%)	371.46M
SIRISirius XM Holdings Inc	$ 2.94 (1.38%)	330.66M
AAPLApple Inc	$ 207.49 (-1.04%)	246.38M
NKLANikola Corporation	$ 0.3466 (5.16%)	193.36M